Publicacións (264) Publicacións nas que participase algún/ha investigador/a

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration

    The Lancet HIV, Vol. 11, Núm. 10, pp. e660-e669

  3. Clinical usefulness of serum angiotensin converting enzyme in silicosis

    Pulmonology, Vol. 30, Núm. 4, pp. 370-377

  4. Correlating Histopathological Microscopic Images of Creutzfeldt–Jakob Disease with Clinical Typology Using Graph Theory and Artificial Intelligence

    Machine Learning and Knowledge Extraction, Vol. 6, Núm. 3, pp. 2018-2032

  5. Cross-sectional analysis of a cohort of people over 65 years of age living with HIV

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 6, pp. 317-320

  6. Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 1

  7. Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers

    Frontiers in Immunology, Vol. 15

  8. Laboratory Report of HIV-1 Low-Level Viremia

    Open Forum Infectious Diseases

  9. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

2023

  1. 1586 - CARACTERÍSTICAS DE LA INFECCIÓN POR SARS-COV-2 EN PACIENTES EN TRATAMIENTO CON ANTICUERPOS MONOCLONALES ANTI-CD20 DESDE EL INICIO DE LA PANDEMIA

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S426-S427

  2. 1706 - ¿COMO HEMOS MANEJADO LA INFECCIÓN POR SARS-COV-2 EN PACIENTES DIAGNOSTICADOS DE NEOPLASIAS HEMATOLÓGICAS EN TRATAMIENTO CON RITUXIMAB?

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S428-S429

  3. 7 - IMPACTO DE LA PANDEMIA POR COVID-19 EN LA INCIDENCIA DE COLONIZACIÓN-INFECCIÓN POR STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA.

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S806-S807

  4. A Randomized Trial of Dolutegravir Plus Darunavir/ Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

    Open Forum Infectious Diseases, Vol. 10, Núm. 11

  5. BACTERIEMIA EN PERSONAS QUE VIVEN CON VIH A LO LARGO DE 34 AÑOS

    Revista Clínica Española, Vol. 223, Núm. Supl 2, pp. S706-S707

  6. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  7. Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

    Respiratory Research, Vol. 24, Núm. 1

  8. High Levels of IL-1β, TNF-α and MIP-1α One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients

    Microorganisms, Vol. 11, Núm. 10

  9. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

    Frontiers in Immunology, Vol. 14

  10. Impact of Methylprednisolone Pulse on the Mortality of Patients With Acute Respiratory Distress Syndrome Secondary to COVID-19

    Infectious Diseases in Clinical Practice, Vol. 31, Núm. 6

  11. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases